In this study, no specific disease is examined.
Conditions
Interventions
Intervention 1: "Intervention group:" The clinical supervision model for the intervention group is done in three stages: In the first stage, a session is held outside the student shift program, checkl
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Students have entered the internship course Students have passed their pharmacology unit with a passing grade
Exclusion criteria
Exclusion criteria: Participate in medication safety classes outside the university curriculum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication Safety Score by Medication Safety Critical Element Checklist. Timepoint: Before the intervention (in both intervention and control groups) and in each of the 5 sessions of the clinical supervision model in the intervention group (for the control group in 5 sessions with normal supervision). Method of measurement: Medication Safety Critical Element Checklist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Medication Safety Knowledge Assessment Score according to the Medication Safety Knowledge Assessment Questionnaire. Timepoint: Before and after the intervention (in both intervention and control groups). Method of measurement: Medication Safety Knowledge Assessment Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Sedigheh Farzi
Esfahan University of Medical Sciences
Outcome results
None listed